116 related articles for article (PubMed ID: 16894287)
21. Nutrition, inflammation and chronic kidney disease.
Ikizler TA
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):162-7. PubMed ID: 18277149
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions.
McNamara D; El-Omar E
Dig Liver Dis; 2008 Jul; 40(7):504-9. PubMed ID: 18486572
[TBL] [Abstract][Full Text] [Related]
23. Toward a molecular explanation for cross-presentation of antigens to the immune system.
Khor B; Makar RS
Transfus Med Rev; 2008 Jul; 22(3):188-201. PubMed ID: 18572095
[TBL] [Abstract][Full Text] [Related]
24. Immunologic and molecular mechanisms in inflammatory bowel disease.
Ince MN; Elliott DE
Surg Clin North Am; 2007 Jun; 87(3):681-96. PubMed ID: 17560420
[TBL] [Abstract][Full Text] [Related]
25. Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis.
Kondo E; Yoshino T
Pathol Int; 2007 Jul; 57(7):391-7. PubMed ID: 17587238
[TBL] [Abstract][Full Text] [Related]
26. Immunodeficiency-associated lymphomas.
Tran H; Nourse J; Hall S; Green M; Griffiths L; Gandhi MK
Blood Rev; 2008 Sep; 22(5):261-81. PubMed ID: 18456377
[TBL] [Abstract][Full Text] [Related]
27. Indolent lymphomas: current and emerging treatment approaches.
Maloney D; Kahl BS; Dreyling M
Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism in the hematologic malignancies.
Falanga A; Marchetti M
J Clin Oncol; 2009 Oct; 27(29):4848-57. PubMed ID: 19752334
[TBL] [Abstract][Full Text] [Related]
29. Is defective lymphatic drainage a trigger for lymphoid neogenesis?
Thaunat O; Kerjaschki D; Nicoletti A
Trends Immunol; 2006 Oct; 27(10):441-5. PubMed ID: 16920402
[TBL] [Abstract][Full Text] [Related]
30. Is inhalation exposure to formaldehyde a biologically plausible cause of lymphohematopoietic malignancies?
Pyatt D; Natelson E; Golden R
Regul Toxicol Pharmacol; 2008 Jun; 51(1):119-33. PubMed ID: 18440686
[TBL] [Abstract][Full Text] [Related]
31. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
Weisman D; Hakimian E; Ho GJ
Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
[TBL] [Abstract][Full Text] [Related]
32. The role of neuromediators in ocular allergy.
Micera A; Lambiase A; Bonini S
Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):466-71. PubMed ID: 18769203
[TBL] [Abstract][Full Text] [Related]
33. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer.
Lee G; Walser TC; Dubinett SM
Curr Opin Pulm Med; 2009 Jul; 15(4):303-7. PubMed ID: 19417670
[TBL] [Abstract][Full Text] [Related]
34. Genetic aspects of inflammation and cancer.
Hold GL; El-Omar EM
Biochem J; 2008 Mar; 410(2):225-35. PubMed ID: 18254728
[TBL] [Abstract][Full Text] [Related]
35. Predicting the outcome in non-Hodgkin lymphoma with molecular markers.
Kwong YL
Br J Haematol; 2007 May; 137(4):273-87. PubMed ID: 17408399
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
37. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
Mason NJ; Coughlin CM; Overley B; Cohen JN; Mitchell EL; Colligon TA; Clifford CA; Zurbriggen A; Sorenmo KU; Vonderheide RH
Gene Ther; 2008 Jul; 15(13):955-65. PubMed ID: 18337841
[TBL] [Abstract][Full Text] [Related]
38. Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma.
Winter JN
Curr Opin Hematol; 2007 Jul; 14(4):360-8. PubMed ID: 17534162
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular and oral disease interactions: what is the evidence?
Ford PJ; Yamazaki K; Seymour GJ
Prim Dent Care; 2007 Apr; 14(2):59-66. PubMed ID: 17462139
[TBL] [Abstract][Full Text] [Related]
40. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
